2019 ਦਾ ਸਰਵਉਤਮ ਇਕੁਇਟੀ ਮਿutਚੁਅਲ ਫੰਡ

Updated on September 2, 2025 , 724 views

ਇਕਵਿਟੀ ਫੰਡ ਉਹ ਉਹ ਹੁੰਦੇ ਹਨ ਜਿਨ੍ਹਾਂ ਦੇ ਇਕੱਠੇ ਕੀਤੇ ਫੰਡ ਦੀ ਰਕਮ ਵੱਖ-ਵੱਖ ਕੰਪਨੀਆਂ ਦੇ ਇਕੁਇਟੀ ਅਤੇ ਇਕੁਇਟੀ ਨਾਲ ਜੁੜੇ ਯੰਤਰਾਂ ਵਿੱਚ ਲਗਾਈ ਜਾਂਦੀ ਹੈ. ਇਕੁਇਟੀ ਫੰਡਾਂ ਨੂੰ ਇੱਕ ਮੱਧਮ ਅਤੇ ਉੱਚ- ਵਾਲੇ ਲੋਕਾਂ ਲਈ ਲੰਬੇ ਸਮੇਂ ਦੇ ਨਿਵੇਸ਼ ਵਿਕਲਪ ਵਜੋਂ ਮੰਨਿਆ ਜਾਂਦਾ ਹੈਜੋਖਮ ਭੁੱਖ. ਇਕਵਿਟੀ ਫੰਡਾਂ ਦੀਆਂ ਕਈ ਕਿਸਮਾਂ ਸ਼ਾਮਲ ਹਨਵੱਡੇ ਕੈਪ ਫੰਡ,ਮਿਡ ਕੈਪ ਫੰਡ,ਸਮਾਲ ਕੈਪ ਫੰਡ,ELSS, ਇਤਆਦਿ. ਸਾਲ 2019 ਵਿਚ, ਇਕਵਿਟੀ ਬਾਜ਼ਾਰਾਂ ਵਿਚ ਉਛਾਲ ਦੇਖਣ ਨੂੰ ਮਿਲਿਆ ਜਿਸ ਕਾਰਨ ਜ਼ਿਆਦਾਤਰ ਇਕਵਿਟੀ ਫੰਡ ਸ਼੍ਰੇਣੀਆਂ ਨੇ ਵਧੀਆ ਪ੍ਰਦਰਸ਼ਨ ਕੀਤਾ. ਇਨ੍ਹਾਂ ਫੰਡਾਂ ਦੀ ਕਾਰਗੁਜ਼ਾਰੀ ਬਹੁਤ ਸਾਰੇ ਮੈਕਰੋ ਅਤੇ ਮਾਈਕਰੋਕੋਮੋਨਿਕ ਮਾਪਦੰਡਾਂ 'ਤੇ ਨਿਰਭਰ ਕਰਦੀ ਹੈ ਜਿਵੇਂ ਕਿ ਉਦਯੋਗ ਦੀ ਕਾਰਗੁਜ਼ਾਰੀ, ਕੰਪਨੀ ਦੀ ਕਾਰਗੁਜ਼ਾਰੀ, ਕਮਾਈ ਅਤੇ ਕੰਪਨੀਆਂ ਦੀ ਮੁਨਾਫਾ, ਇਸ ਦੀਆਂ ਭਵਿੱਖ ਦੀਆਂ ਸੰਭਾਵਨਾਵਾਂ ਅਤੇ ਹੋਰ. ਚੋਟੀ ਅਤੇਸਰਬੋਤਮ ਇਕੁਇਟੀ ਫੰਡ ਸਾਲ 2019 ਲਈ ਹੇਠ ਦਿੱਤੇ ਅਨੁਸਾਰ ਹਨ.

Ready to Invest?
Talk to our investment specialist

ਪ੍ਰਦਰਸ਼ਨ ਦੇ ਅਧਾਰ ਤੇ 2019 ਦੇ ਚੋਟੀ ਦੇ 10 ਇਕੁਇਟੀ ਮਿutਚੁਅਲ ਫੰਡ

Fund	NAV	Net Assets (Cr)	2024 (%)	2023 (%)	2022 (%)	2021 (%)	2020 (%)
Motilal Oswal Midcap 30 Fund Growth	₹104.504 ↓ -0.75	₹33,609	57.1	41.7	10.7	55.8	9.3
LIC MF Infrastructure Fund Growth	₹48.4222 ↓ -0.32	₹1,038	47.8	44.4	7.9	46.6	-0.1
Motilal Oswal Long Term Equity Fund Growth	₹50.861 ↓ -0.37	₹4,402	47.7	37	1.8	32.1	8.8
Motilal Oswal Multicap 35 Fund Growth	₹62.4989 ↓ -0.19	₹13,727	45.7	31	-3	15.3	10.3
Invesco India Mid Cap Fund Growth	₹179.56 ↓ -0.76	₹7,802	43.1	34.1	0.5	43.1	24.4
UTI Healthcare Fund Growth	₹292.526 ↑ 0.58	₹1,146	42.9	38.2	-12.3	19.1	67.4
SBI Healthcare Opportunities Fund Growth	₹432.494 ↑ 0.13	₹4,027	42.2	38.2	-6	20.1	65.8
TATA India Pharma & Healthcare Fund Growth	₹30.7978 ↑ 0.01	₹1,339	40.4	36.6	-8	19.1	64.4
IDBI Small Cap Fund Growth	₹30.1966 ↓ -0.09	₹618	40	33.4	2.4	64.7	19
Bandhan Infrastructure Fund Growth	₹49.312 ↓ -0.39	₹1,676	39.3	50.3	1.7	64.8	6.3
Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 4 Sep 25

Research Highlights & Commentary of 10 Funds showcased

Commentary	Motilal Oswal Midcap 30 Fund	LIC MF Infrastructure Fund	Motilal Oswal Long Term Equity Fund	Motilal Oswal Multicap 35 Fund	Invesco India Mid Cap Fund	UTI Healthcare Fund	SBI Healthcare Opportunities Fund	TATA India Pharma & Healthcare Fund	IDBI Small Cap Fund	Bandhan Infrastructure Fund
Point 1	Highest AUM (₹33,609 Cr).	Bottom quartile AUM (₹1,038 Cr).	Upper mid AUM (₹4,402 Cr).	Top quartile AUM (₹13,727 Cr).	Upper mid AUM (₹7,802 Cr).	Bottom quartile AUM (₹1,146 Cr).	Upper mid AUM (₹4,027 Cr).	Lower mid AUM (₹1,339 Cr).	Bottom quartile AUM (₹618 Cr).	Lower mid AUM (₹1,676 Cr).
Point 2	Established history (11+ yrs).	Established history (17+ yrs).	Established history (10+ yrs).	Established history (11+ yrs).	Established history (18+ yrs).	Oldest track record among peers (26 yrs).	Established history (20+ yrs).	Established history (9+ yrs).	Established history (8+ yrs).	Established history (14+ yrs).
Point 3	Rating: 3★ (upper mid).	Not Rated.	Not Rated.	Top rated.	Rating: 2★ (upper mid).	Rating: 1★ (lower mid).	Rating: 2★ (upper mid).	Not Rated.	Not Rated.	Rating: 5★ (top quartile).
Point 4	Risk profile: Moderately High.	Risk profile: High.	Risk profile: Moderately High.	Risk profile: Moderately High.	Risk profile: Moderately High.	Risk profile: High.	Risk profile: High.	Risk profile: High.	Risk profile: Moderately High.	Risk profile: High.
Point 5	5Y return: 33.60% (top quartile).	5Y return: 30.76% (upper mid).	5Y return: 25.04% (lower mid).	5Y return: 19.86% (bottom quartile).	5Y return: 27.98% (upper mid).	5Y return: 19.01% (bottom quartile).	5Y return: 20.54% (lower mid).	5Y return: 19.34% (bottom quartile).	5Y return: 27.82% (upper mid).	5Y return: 32.31% (top quartile).
Point 6	3Y return: 28.31% (top quartile).	3Y return: 26.17% (upper mid).	3Y return: 24.47% (lower mid).	3Y return: 22.83% (bottom quartile).	3Y return: 26.98% (top quartile).	3Y return: 25.73% (lower mid).	3Y return: 26.65% (upper mid).	3Y return: 24.08% (bottom quartile).	3Y return: 16.88% (bottom quartile).	3Y return: 26.03% (upper mid).
Point 7	1Y return: 1.20% (upper mid).	1Y return: -6.98% (bottom quartile).	1Y return: -2.60% (lower mid).	1Y return: 4.11% (upper mid).	1Y return: 8.63% (top quartile).	1Y return: 3.23% (upper mid).	1Y return: 6.02% (top quartile).	1Y return: -0.84% (lower mid).	1Y return: -10.11% (bottom quartile).	1Y return: -11.15% (bottom quartile).
Point 8	Alpha: 3.70 (upper mid).	Alpha: 1.35 (lower mid).	Alpha: 11.36 (top quartile).	Alpha: 10.18 (top quartile).	Alpha: 0.00 (bottom quartile).	Alpha: 0.67 (lower mid).	Alpha: 3.04 (upper mid).	Alpha: 2.48 (upper mid).	Alpha: -3.30 (bottom quartile).	Alpha: 0.00 (bottom quartile).
Point 9	Sharpe: -0.11 (lower mid).	Sharpe: -0.30 (bottom quartile).	Sharpe: 0.04 (lower mid).	Sharpe: 0.11 (upper mid).	Sharpe: 0.32 (upper mid).	Sharpe: 0.43 (top quartile).	Sharpe: 0.60 (top quartile).	Sharpe: 0.16 (upper mid).	Sharpe: -0.45 (bottom quartile).	Sharpe: -0.69 (bottom quartile).
Point 10	Information ratio: 0.44 (upper mid).	Information ratio: 0.40 (upper mid).	Information ratio: 0.92 (top quartile).	Information ratio: 0.80 (top quartile).	Information ratio: 0.00 (lower mid).	Information ratio: -0.06 (bottom quartile).	Information ratio: 0.38 (lower mid).	Information ratio: 0.60 (upper mid).	Information ratio: -0.66 (bottom quartile).	Information ratio: 0.00 (bottom quartile).

Motilal Oswal Midcap 30 Fund

Highest AUM (₹33,609 Cr).
Established history (11+ yrs).
Rating: 3★ (upper mid).
Risk profile: Moderately High.
5Y return: 33.60% (top quartile).
3Y return: 28.31% (top quartile).
1Y return: 1.20% (upper mid).
Alpha: 3.70 (upper mid).
Sharpe: -0.11 (lower mid).
Information ratio: 0.44 (upper mid).

LIC MF Infrastructure Fund

Bottom quartile AUM (₹1,038 Cr).
Established history (17+ yrs).
Not Rated.
Risk profile: High.
5Y return: 30.76% (upper mid).
3Y return: 26.17% (upper mid).
1Y return: -6.98% (bottom quartile).
Alpha: 1.35 (lower mid).
Sharpe: -0.30 (bottom quartile).
Information ratio: 0.40 (upper mid).

Motilal Oswal Long Term Equity Fund

Upper mid AUM (₹4,402 Cr).
Established history (10+ yrs).
Not Rated.
Risk profile: Moderately High.
5Y return: 25.04% (lower mid).
3Y return: 24.47% (lower mid).
1Y return: -2.60% (lower mid).
Alpha: 11.36 (top quartile).
Sharpe: 0.04 (lower mid).
Information ratio: 0.92 (top quartile).

Motilal Oswal Multicap 35 Fund

Top quartile AUM (₹13,727 Cr).
Established history (11+ yrs).
Top rated.
Risk profile: Moderately High.
5Y return: 19.86% (bottom quartile).
3Y return: 22.83% (bottom quartile).
1Y return: 4.11% (upper mid).
Alpha: 10.18 (top quartile).
Sharpe: 0.11 (upper mid).
Information ratio: 0.80 (top quartile).

Invesco India Mid Cap Fund

Upper mid AUM (₹7,802 Cr).
Established history (18+ yrs).
Rating: 2★ (upper mid).
Risk profile: Moderately High.
5Y return: 27.98% (upper mid).
3Y return: 26.98% (top quartile).
1Y return: 8.63% (top quartile).
Alpha: 0.00 (bottom quartile).
Sharpe: 0.32 (upper mid).
Information ratio: 0.00 (lower mid).

UTI Healthcare Fund

Bottom quartile AUM (₹1,146 Cr).
Oldest track record among peers (26 yrs).
Rating: 1★ (lower mid).
Risk profile: High.
5Y return: 19.01% (bottom quartile).
3Y return: 25.73% (lower mid).
1Y return: 3.23% (upper mid).
Alpha: 0.67 (lower mid).
Sharpe: 0.43 (top quartile).
Information ratio: -0.06 (bottom quartile).

SBI Healthcare Opportunities Fund

Upper mid AUM (₹4,027 Cr).
Established history (20+ yrs).
Rating: 2★ (upper mid).
Risk profile: High.
5Y return: 20.54% (lower mid).
3Y return: 26.65% (upper mid).
1Y return: 6.02% (top quartile).
Alpha: 3.04 (upper mid).
Sharpe: 0.60 (top quartile).
Information ratio: 0.38 (lower mid).

TATA India Pharma & Healthcare Fund

Lower mid AUM (₹1,339 Cr).
Established history (9+ yrs).
Not Rated.
Risk profile: High.
5Y return: 19.34% (bottom quartile).
3Y return: 24.08% (bottom quartile).
1Y return: -0.84% (lower mid).
Alpha: 2.48 (upper mid).
Sharpe: 0.16 (upper mid).
Information ratio: 0.60 (upper mid).

IDBI Small Cap Fund

Bottom quartile AUM (₹618 Cr).
Established history (8+ yrs).
Not Rated.
Risk profile: Moderately High.
5Y return: 27.82% (upper mid).
3Y return: 16.88% (bottom quartile).
1Y return: -10.11% (bottom quartile).
Alpha: -3.30 (bottom quartile).
Sharpe: -0.45 (bottom quartile).
Information ratio: -0.66 (bottom quartile).

Bandhan Infrastructure Fund

Lower mid AUM (₹1,676 Cr).
Established history (14+ yrs).
Rating: 5★ (top quartile).
Risk profile: High.
5Y return: 32.31% (top quartile).
3Y return: 26.03% (upper mid).
1Y return: -11.15% (bottom quartile).
Alpha: 0.00 (bottom quartile).
Sharpe: -0.69 (bottom quartile).
Information ratio: 0.00 (bottom quartile).

2019 ਦੇ ਚੋਟੀ ਦੇ ਅਤੇ ਸਰਬੋਤਮ ਇਕੁਇਟੀ ਮਿutਚੁਅਲ ਫੰਡ

1. Motilal Oswal Midcap 30 Fund

(Erstwhile Motilal Oswal MOSt Focused Midcap 30 Fund)

The investment objective of the Scheme is to achieve long term capital appreciation by investing in a maximum of 30 quality mid-cap companies having long-term competitive advantages and potential for growth. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved.

Research Highlights for Motilal Oswal Midcap 30 Fund

Highest AUM (₹33,609 Cr).
Established history (11+ yrs).
Rating: 3★ (upper mid).
Risk profile: Moderately High.
5Y return: 33.60% (top quartile).
3Y return: 28.31% (top quartile).
1Y return: 1.20% (upper mid).
Alpha: 3.70 (upper mid).
Sharpe: -0.11 (lower mid).
Information ratio: 0.44 (upper mid).
Higher exposure to Technology vs peer median.
Higher exposure to Cash Equivalent (bond sector) vs peer median.
Equity-heavy allocation (~82%).
Largest holding Dixon Technologies (India) Ltd (~10.5%).

Below is the key information for Motilal Oswal Midcap 30 Fund

Motilal Oswal Midcap 30 Fund Growth
Launch Date	24 Feb 14
NAV (04 Sep 25)	₹104.504 ↓ -0.75 (-0.72 %)
Net Assets (Cr)	₹33,609 on 31 Jul 25
Category	Equity - Mid Cap
AMC	Motilal Oswal Asset Management Co. Ltd
Rating	☆☆☆
Risk	Moderately High
Expense Ratio	1.56
Sharpe Ratio	-0.11
Information Ratio	0.44
Alpha Ratio	3.7
Min Investment	5,000
Min SIP Investment	500
Exit Load	0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
31 Aug 20	₹10,000
31 Aug 21	₹16,108
31 Aug 22	₹20,215
31 Aug 23	₹25,558
31 Aug 24	₹41,687
31 Aug 25	₹41,704

Motilal Oswal Midcap 30 Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹689,048.
Net Profit of ₹389,048 Invest Now

Returns for Motilal Oswal Midcap 30 Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 4 Sep 25

Duration	Returns
1 Month	1.4%
3 Month	4.6%
6 Month	17.6%
1 Year	1.2%
3 Year	28.3%
5 Year	33.6%
10 Year
15 Year
Since launch	22.6%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	57.1%
2023	41.7%
2022	10.7%
2021	55.8%
2020	9.3%
2019	9.7%
2018	-12.7%
2017	30.8%
2016	5.2%
2015	16.5%

Fund Manager information for Motilal Oswal Midcap 30 Fund

Name	Since	Tenure
Ajay Khandelwal	1 Oct 24	0.92 Yr.
Niket Shah	1 Jul 20	5.17 Yr.
Rakesh Shetty	22 Nov 22	2.78 Yr.
Sunil Sawant	1 Jul 24	1.17 Yr.

Data below for Motilal Oswal Midcap 30 Fund as on 31 Jul 25

Equity Sector Allocation

Sector	Value
Technology	34.22%
Industrials	18.95%
Consumer Cyclical	16.7%
Communication Services	3.85%
Health Care	3.7%
Financial Services	2.6%
Real Estate	2.03%

Asset Allocation

Asset Class	Value
Cash	17.96%
Equity	82.04%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Dixon Technologies (India) Ltd (Technology) Equity, Since 31 Mar 23 \| DIXON	11%	₹3,537 Cr	2,099,999 ↑ 100,000
Coforge Ltd (Technology) Equity, Since 31 Mar 23 \| COFORGE	9%	₹3,147 Cr	18,000,050 ↑ 50
Kalyan Jewellers India Ltd (Consumer Cyclical) Equity, Since 29 Feb 24 \| KALYANKJIL	9%	₹2,978 Cr	50,076,240 ↑ 5,076,240
Persistent Systems Ltd (Technology) Equity, Since 31 Jan 23 \| PERSISTENT	8%	₹2,787 Cr	5,400,005 ↑ 150,005
Trent Ltd (Consumer Cyclical) Equity, Since 30 Nov 24 \| 500251	8%	₹2,634 Cr	5,250,000 ↑ 257,861
Polycab India Ltd (Industrials) Equity, Since 30 Sep 23 \| POLYCAB	6%	₹1,876 Cr	2,750,000 ↑ 200,000
One97 Communications Ltd (Technology) Equity, Since 30 Sep 24 \| 543396	4%	₹1,511 Cr	13,869,997 ↑ 3,773,933
KEI Industries Ltd (Industrials) Equity, Since 30 Nov 24 \| KEI	4%	₹1,345 Cr	3,500,000
Bharti Hexacom Ltd (Communication Services) Equity, Since 31 Oct 24 \| BHARTIHEXA	4%	₹1,293 Cr	7,000,000 ↑ 250,000
Max Healthcare Institute Ltd Ordinary Shares (Healthcare) Equity, Since 31 Mar 24 \| MAXHEALTH	4%	₹1,242 Cr	9,969,361

2. LIC MF Infrastructure Fund

The investment objective of the scheme is to provide long term growth from a portfolio of equity / equity related instruments of companies engaged either directly or indirectly in the infrastructure sector.

Research Highlights for LIC MF Infrastructure Fund

Bottom quartile AUM (₹1,038 Cr).
Established history (17+ yrs).
Not Rated.
Risk profile: High.
5Y return: 30.76% (upper mid).
3Y return: 26.17% (upper mid).
1Y return: -6.98% (bottom quartile).
Alpha: 1.35 (lower mid).
Sharpe: -0.30 (bottom quartile).
Information ratio: 0.40 (upper mid).
Higher exposure to Industrials vs peer median.
Top bond sector: Cash Equivalent.
Equity-heavy allocation (~95%).
High-quality debt (AAA/AA ~100%).
Largest holding Shakti Pumps (India) Ltd (~6.0%).

Below is the key information for LIC MF Infrastructure Fund

LIC MF Infrastructure Fund Growth
Launch Date	29 Feb 08
NAV (04 Sep 25)	₹48.4222 ↓ -0.32 (-0.66 %)
Net Assets (Cr)	₹1,038 on 31 Jul 25
Category	Equity - Sectoral
AMC	LIC Mutual Fund Asset Mgmt Co Ltd
Rating	Not Rated
Risk	High
Expense Ratio	2.21
Sharpe Ratio	-0.3
Information Ratio	0.4
Alpha Ratio	1.35
Min Investment	5,000
Min SIP Investment	1,000
Exit Load	0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
31 Aug 20	₹10,000
31 Aug 21	₹16,396
31 Aug 22	₹18,753
31 Aug 23	₹23,082
31 Aug 24	₹41,121
31 Aug 25	₹37,159

LIC MF Infrastructure Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹642,208.
Net Profit of ₹342,208 Invest Now

Returns for LIC MF Infrastructure Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 4 Sep 25

Duration	Returns
1 Month	-1.9%
3 Month	-2%
6 Month	21.8%
1 Year	-7%
3 Year	26.2%
5 Year	30.8%
10 Year
15 Year
Since launch	9.4%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	47.8%
2023	44.4%
2022	7.9%
2021	46.6%
2020	-0.1%
2019	13.3%
2018	-14.6%
2017	42.2%
2016	-2.2%
2015	-6.2%

Fund Manager information for LIC MF Infrastructure Fund

Name	Since	Tenure
Yogesh Patil	18 Sep 20	4.96 Yr.
Mahesh Bendre	1 Jul 24	1.17 Yr.

Data below for LIC MF Infrastructure Fund as on 31 Jul 25

Equity Sector Allocation

Sector	Value
Industrials	49.62%
Basic Materials	8.63%
Financial Services	8.16%
Consumer Cyclical	6.96%
Utility	6.68%
Technology	4.17%
Health Care	3.87%
Real Estate	3.65%
Communication Services	2.48%
Energy	0.92%

Asset Allocation

Asset Class	Value
Cash	4.87%
Equity	95.13%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Shakti Pumps (India) Ltd (Industrials) Equity, Since 31 Mar 24 \| SHAKTIPUMP	6%	₹62 Cr	693,857 ↑ 217,865
Larsen & Toubro Ltd (Industrials) Equity, Since 30 Apr 09 \| LT	4%	₹40 Cr	109,584 ↑ 6,093
REC Ltd (Financial Services) Equity, Since 31 Jul 23 \| 532955	3%	₹36 Cr	911,009 ↑ 289,485
Apollo Hospitals Enterprise Ltd (Healthcare) Equity, Since 30 Jun 25 \| APOLLOHOSP	3%	₹35 Cr	46,843 ↑ 6,976
Garware Hi-Tech Films Ltd (Basic Materials) Equity, Since 31 Aug 23 \| 500655	3%	₹33 Cr	94,287
Schneider Electric Infrastructure Ltd (Industrials) Equity, Since 31 Dec 23 \| SCHNEIDER	3%	₹32 Cr	319,302
Afcons Infrastructure Ltd (Industrials) Equity, Since 31 Oct 24 \| AFCONS	3%	₹31 Cr	769,765
Tata Power Co Ltd (Utilities) Equity, Since 29 Feb 24 \| 500400	3%	₹29 Cr	724,927
Avalon Technologies Ltd (Technology) Equity, Since 31 Jul 23 \| AVALON	3%	₹26 Cr	310,615 ↓ -6,871
Mahindra Lifespace Developers Ltd (Real Estate) Equity, Since 30 Jun 24 \| MAHLIFE	2%	₹25 Cr	666,245

3. Motilal Oswal Long Term Equity Fund

(Erstwhile Motilal Oswal MOSt Focused Long Term Fund)

The investment objective of the Scheme is to generate long-term capital appreciation from a diversified portfolio of predominantly equity and equity related instruments. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved.

Research Highlights for Motilal Oswal Long Term Equity Fund

Upper mid AUM (₹4,402 Cr).
Established history (10+ yrs).
Not Rated.
Risk profile: Moderately High.
5Y return: 25.04% (lower mid).
3Y return: 24.47% (lower mid).
1Y return: -2.60% (lower mid).
Alpha: 11.36 (top quartile).
Sharpe: 0.04 (lower mid).
Information ratio: 0.92 (top quartile).
Top sector: Industrials.
Top bond sector: Cash Equivalent.
Equity-heavy allocation (~98%).
Largest holding Eternal Ltd (~6.3%).

Below is the key information for Motilal Oswal Long Term Equity Fund

Motilal Oswal Long Term Equity Fund Growth
Launch Date	21 Jan 15
NAV (04 Sep 25)	₹50.861 ↓ -0.37 (-0.73 %)
Net Assets (Cr)	₹4,402 on 31 Jul 25
Category	Equity - ELSS
AMC	Motilal Oswal Asset Management Co. Ltd
Rating	Not Rated
Risk	Moderately High
Expense Ratio	1.65
Sharpe Ratio	0.04
Information Ratio	0.92
Alpha Ratio	11.36
Min Investment	500
Min SIP Investment	500
Exit Load	NIL

Growth of 10,000 investment over the years.

Date	Value
31 Aug 20	₹10,000
31 Aug 21	₹16,372
31 Aug 22	₹16,008
31 Aug 23	₹19,372
31 Aug 24	₹31,421
31 Aug 25	₹29,948

Motilal Oswal Long Term Equity Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹570,326.
Net Profit of ₹270,326 Invest Now

Returns for Motilal Oswal Long Term Equity Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 4 Sep 25

Duration	Returns
1 Month	-2.1%
3 Month	-1.6%
6 Month	22.1%
1 Year	-2.6%
3 Year	24.5%
5 Year	25%
10 Year
15 Year
Since launch	16.6%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	47.7%
2023	37%
2022	1.8%
2021	32.1%
2020	8.8%
2019	13.2%
2018	-8.7%
2017	44%
2016	12.5%
2015

Fund Manager information for Motilal Oswal Long Term Equity Fund

Name	Since	Tenure
Ajay Khandelwal	11 Dec 23	1.73 Yr.
Rakesh Shetty	22 Nov 22	2.78 Yr.
Atul Mehra	1 Oct 24	0.92 Yr.

Data below for Motilal Oswal Long Term Equity Fund as on 31 Jul 25

Equity Sector Allocation

Sector	Value
Industrials	31.5%
Financial Services	22.55%
Consumer Cyclical	17.85%
Technology	11.38%
Basic Materials	5.89%
Real Estate	4.55%
Health Care	3.01%
Communication Services	1.57%

Asset Allocation

Asset Class	Value
Cash	1.68%
Equity	98.32%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Eternal Ltd (Consumer Cyclical) Equity, Since 31 Oct 23 \| 543320	6%	₹276 Cr	8,970,581
Prestige Estates Projects Ltd (Real Estate) Equity, Since 31 Oct 23 \| PRESTIGE	5%	₹200 Cr	1,231,856 ↑ 176,651
Amber Enterprises India Ltd Ordinary Shares (Consumer Cyclical) Equity, Since 31 Mar 24 \| AMBER	4%	₹191 Cr	240,350
Multi Commodity Exchange of India Ltd (Financial Services) Equity, Since 29 Feb 24 \| MCX	4%	₹191 Cr	248,438
Kaynes Technology India Ltd (Industrials) Equity, Since 30 Jun 23 \| KAYNES	4%	₹179 Cr	289,593 ↓ -8,158
Bharat Dynamics Ltd Ordinary Shares (Industrials) Equity, Since 31 Dec 23 \| BDL	4%	₹171 Cr	1,056,315
Gujarat Fluorochemicals Ltd Ordinary Shares (Basic Materials) Equity, Since 28 Feb 23 \| FLUOROCHEM	4%	₹155 Cr	430,073 ↑ 12,083
Suzlon Energy Ltd (Industrials) Equity, Since 31 Jan 24 \| SUZLON	3%	₹152 Cr	24,702,337
Bharat Electronics Ltd (Industrials) Equity, Since 30 Apr 24 \| BEL	3%	₹147 Cr	3,832,775 ↓ -117,225
Piramal Enterprises Ltd (Financial Services) Equity, Since 31 Jul 24 \| 500302	3%	₹146 Cr	1,168,384

4. Motilal Oswal Multicap 35 Fund

(Erstwhile Motilal Oswal MOSt Focused Multicap 35 Fund)

The investment objective of the Scheme is to achieve long term capital appreciation by primarily investing in a maximum of 35 equity & equity related instruments across sectors and market-capitalization levels.However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved.

Research Highlights for Motilal Oswal Multicap 35 Fund

Top quartile AUM (₹13,727 Cr).
Established history (11+ yrs).
Top rated.
Risk profile: Moderately High.
5Y return: 19.86% (bottom quartile).
3Y return: 22.83% (bottom quartile).
1Y return: 4.11% (upper mid).
Alpha: 10.18 (top quartile).
Sharpe: 0.11 (upper mid).
Information ratio: 0.80 (top quartile).
Higher exposure to Technology vs peer median.
Top bond sector: Cash Equivalent.
Equity-heavy allocation (~93%).
Largest holding Coforge Ltd (~10.2%).

Below is the key information for Motilal Oswal Multicap 35 Fund

Motilal Oswal Multicap 35 Fund Growth
Launch Date	28 Apr 14
NAV (04 Sep 25)	₹62.4989 ↓ -0.19 (-0.31 %)
Net Assets (Cr)	₹13,727 on 31 Jul 25
Category	Equity - Multi Cap
AMC	Motilal Oswal Asset Management Co. Ltd
Rating	☆☆☆☆☆
Risk	Moderately High
Expense Ratio	1.77
Sharpe Ratio	0.11
Information Ratio	0.8
Alpha Ratio	10.18
Min Investment	5,000
Min SIP Investment	500
Exit Load	0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
31 Aug 20	₹10,000
31 Aug 21	₹14,206
31 Aug 22	₹13,436
31 Aug 23	₹15,316
31 Aug 24	₹23,632
31 Aug 25	₹24,334

Motilal Oswal Multicap 35 Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹493,520.
Net Profit of ₹193,520 Invest Now

Returns for Motilal Oswal Multicap 35 Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 4 Sep 25

Duration	Returns
1 Month	0.6%
3 Month	4.9%
6 Month	16.6%
1 Year	4.1%
3 Year	22.8%
5 Year	19.9%
10 Year
15 Year
Since launch	17.5%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	45.7%
2023	31%
2022	-3%
2021	15.3%
2020	10.3%
2019	7.9%
2018	-7.8%
2017	43.1%
2016	8.5%
2015	14.6%

Fund Manager information for Motilal Oswal Multicap 35 Fund

Name	Since	Tenure
Ajay Khandelwal	1 Oct 24	0.92 Yr.
Niket Shah	1 Jul 22	3.17 Yr.
Rakesh Shetty	22 Nov 22	2.78 Yr.
Atul Mehra	1 Oct 24	0.92 Yr.
Sunil Sawant	1 Jul 24	1.17 Yr.

Data below for Motilal Oswal Multicap 35 Fund as on 31 Jul 25

Equity Sector Allocation

Sector	Value
Technology	30.71%
Industrials	20.55%
Consumer Cyclical	16.57%
Financial Services	9.39%
Communication Services	8.31%
Utility	5.9%
Health Care	1.82%

Asset Allocation

Asset Class	Value
Cash	6.74%
Equity	93.26%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Coforge Ltd (Technology) Equity, Since 31 May 23 \| COFORGE	10%	₹1,400 Cr	8,005,911 ↓ -119,089
Polycab India Ltd (Industrials) Equity, Since 31 Jan 24 \| POLYCAB	10%	₹1,364 Cr	2,000,000
Dixon Technologies (India) Ltd (Technology) Equity, Since 31 Mar 25 \| DIXON	10%	₹1,347 Cr	800,000 ↑ 175,000
Kalyan Jewellers India Ltd (Consumer Cyclical) Equity, Since 30 Sep 23 \| KALYANKJIL	9%	₹1,189 Cr	20,000,000 ↑ 2,000,000
Persistent Systems Ltd (Technology) Equity, Since 31 Mar 23 \| PERSISTENT	9%	₹1,187 Cr	2,300,000 ↑ 100,000
Trent Ltd (Consumer Cyclical) Equity, Since 31 Jan 23 \| 500251	7%	₹1,004 Cr	2,000,000
CG Power & Industrial Solutions Ltd (Industrials) Equity, Since 31 Jan 25 \| 500093	7%	₹893 Cr	13,499,862 ↑ 1,249,862
Siemens Energy India Ltd (Utilities) Equity, Since 30 Jun 25 \| ENRIN	6%	₹809 Cr	2,500,000 ↑ 49,500
Cholamandalam Investment and Finance Co Ltd (Financial Services) Equity, Since 31 Mar 23 \| CHOLAFIN	5%	₹722 Cr	5,000,000 ↑ 500,000
Bharti Airtel Ltd (Partly Paid Rs.1.25) (Communication Services) Equity, Since 30 Apr 24 \| 890157	5%	₹720 Cr	4,999,500

5. Invesco India Mid Cap Fund

The Scheme seeks to provide long term capital appreciation by investing in a portfolio that is predominantly constituted of equity and equity related instruments of mid cap companies. However, there can be no assurance that the funds objectives will be achieved.

Research Highlights for Invesco India Mid Cap Fund

Upper mid AUM (₹7,802 Cr).
Established history (18+ yrs).
Rating: 2★ (upper mid).
Risk profile: Moderately High.
5Y return: 27.98% (upper mid).
3Y return: 26.98% (top quartile).
1Y return: 8.63% (top quartile).
Alpha: 0.00 (bottom quartile).
Sharpe: 0.32 (upper mid).
Information ratio: 0.00 (lower mid).
Higher exposure to Financial Services vs peer median.
Top bond sector: Cash Equivalent.
Equity-heavy allocation (~98%).
Largest holding BSE Ltd (~4.7%).

Below is the key information for Invesco India Mid Cap Fund

Invesco India Mid Cap Fund Growth
Launch Date	19 Apr 07
NAV (04 Sep 25)	₹179.56 ↓ -0.76 (-0.42 %)
Net Assets (Cr)	₹7,802 on 31 Jul 25
Category	Equity - Mid Cap
AMC	Invesco Asset Management (India) Private Ltd
Rating	☆☆
Risk	Moderately High
Expense Ratio	1.82
Sharpe Ratio	0.32
Information Ratio	0
Alpha Ratio	0
Min Investment	5,000
Min SIP Investment	500
Exit Load	0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
31 Aug 20	₹10,000
31 Aug 21	₹15,770
31 Aug 22	₹16,877
31 Aug 23	₹20,541
31 Aug 24	₹31,641
31 Aug 25	₹33,990

Invesco India Mid Cap Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹598,181.
Net Profit of ₹298,181 Invest Now

Returns for Invesco India Mid Cap Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 4 Sep 25

Duration	Returns
1 Month	0.3%
3 Month	4.9%
6 Month	25.8%
1 Year	8.6%
3 Year	27%
5 Year	28%
10 Year
15 Year
Since launch	17%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	43.1%
2023	34.1%
2022	0.5%
2021	43.1%
2020	24.4%
2019	3.8%
2018	-5.3%
2017	44.3%
2016	1.1%
2015	6.4%

Fund Manager information for Invesco India Mid Cap Fund

Name	Since	Tenure
Aditya Khemani	9 Nov 23	1.81 Yr.
Amit Ganatra	1 Sep 23	2 Yr.

Data below for Invesco India Mid Cap Fund as on 31 Jul 25

Equity Sector Allocation

Sector	Value
Financial Services	29.43%
Health Care	19.75%
Consumer Cyclical	16.17%
Industrials	10.06%
Real Estate	7.86%
Technology	7.74%
Basic Materials	5.42%
Communication Services	1.65%

Asset Allocation

Asset Class	Value
Cash	1.92%
Equity	98.08%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
BSE Ltd (Financial Services) Equity, Since 31 Dec 23 \| BSE	5%	₹369 Cr	1,519,233
Glenmark Pharmaceuticals Ltd (Healthcare) Equity, Since 31 Mar 24 \| 532296	5%	₹358 Cr	1,676,417
Swiggy Ltd (Consumer Cyclical) Equity, Since 30 Nov 24 \| SWIGGY	5%	₹353 Cr	8,755,404 ↑ 957,513
L&T Finance Ltd (Financial Services) Equity, Since 31 Dec 23 \| LTF	4%	₹341 Cr	16,854,973
Prestige Estates Projects Ltd (Real Estate) Equity, Since 30 Nov 23 \| PRESTIGE	4%	₹330 Cr	2,031,622
JK Cement Ltd (Basic Materials) Equity, Since 31 Oct 22 \| JKCEMENT	4%	₹308 Cr	463,277 ↑ 32,043
Max Financial Services Ltd (Financial Services) Equity, Since 30 Nov 23 \| 500271	4%	₹303 Cr	2,016,896 ↑ 174,838
The Federal Bank Ltd (Financial Services) Equity, Since 31 Oct 22 \| FEDERALBNK	4%	₹295 Cr	14,592,638 ↑ 1,181,051
Max Healthcare Institute Ltd Ordinary Shares (Healthcare) Equity, Since 31 Dec 22 \| MAXHEALTH	4%	₹280 Cr	2,246,434
Dixon Technologies (India) Ltd (Technology) Equity, Since 28 Feb 22 \| DIXON	3%	₹262 Cr	155,335

6. UTI Healthcare Fund

(Erstwhile UTI Pharma & Healthcare Fund)

The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors.

Research Highlights for UTI Healthcare Fund

Bottom quartile AUM (₹1,146 Cr).
Oldest track record among peers (26 yrs).
Rating: 1★ (lower mid).
Risk profile: High.
5Y return: 19.01% (bottom quartile).
3Y return: 25.73% (lower mid).
1Y return: 3.23% (upper mid).
Alpha: 0.67 (lower mid).
Sharpe: 0.43 (top quartile).
Information ratio: -0.06 (bottom quartile).
Higher exposure to Health Care vs peer median.
Top bond sector: Cash Equivalent.
Equity-heavy allocation (~98%).
High-quality debt (AAA/AA ~100%).
Largest holding Sun Pharmaceuticals Industries Ltd (~9.8%).

Below is the key information for UTI Healthcare Fund

UTI Healthcare Fund Growth
Launch Date	28 Jun 99
NAV (04 Sep 25)	₹292.526 ↑ 0.58 (0.20 %)
Net Assets (Cr)	₹1,146 on 31 Jul 25
Category	Equity - Sectoral
AMC	UTI Asset Management Company Ltd
Rating	☆
Risk	High
Expense Ratio	2.26
Sharpe Ratio	0.43
Information Ratio	-0.06
Alpha Ratio	0.67
Min Investment	5,000
Min SIP Investment	500
Exit Load	0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
31 Aug 20	₹10,000
31 Aug 21	₹14,183
31 Aug 22	₹12,385
31 Aug 23	₹15,093
31 Aug 24	₹23,487
31 Aug 25	₹24,105

UTI Healthcare Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹493,520.
Net Profit of ₹193,520 Invest Now

Returns for UTI Healthcare Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 4 Sep 25

Duration	Returns
1 Month	0.1%
3 Month	5.5%
6 Month	17.1%
1 Year	3.2%
3 Year	25.7%
5 Year	19%
10 Year
15 Year
Since launch	15%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	42.9%
2023	38.2%
2022	-12.3%
2021	19.1%
2020	67.4%
2019	1.2%
2018	-7.5%
2017	6.2%
2016	-9.7%
2015	12.4%

Fund Manager information for UTI Healthcare Fund

Name	Since	Tenure
Kamal Gada	2 May 22	3.34 Yr.

Data below for UTI Healthcare Fund as on 31 Jul 25

Equity Sector Allocation

Sector	Value
Health Care	96.62%
Basic Materials	1.03%

Asset Allocation

Asset Class	Value
Cash	2.34%
Equity	97.66%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Sun Pharmaceuticals Industries Ltd (Healthcare) Equity, Since 31 Oct 06 \| SUNPHARMA	10%	₹113 Cr	661,016
Cipla Ltd (Healthcare) Equity, Since 31 Jan 03 \| 500087	5%	₹62 Cr	400,000
Ajanta Pharma Ltd (Healthcare) Equity, Since 31 Jul 17 \| 532331	5%	₹55 Cr	200,000 ↓ -10,000
Lupin Ltd (Healthcare) Equity, Since 28 Feb 25 \| 500257	4%	₹49 Cr	255,000 ↑ 55,000
Procter & Gamble Health Ltd (Healthcare) Equity, Since 31 Dec 20 \| PGHL	4%	₹47 Cr	80,283
Dr Reddy's Laboratories Ltd (Healthcare) Equity, Since 28 Feb 18 \| DRREDDY	4%	₹46 Cr	360,000
Glenmark Pharmaceuticals Ltd (Healthcare) Equity, Since 31 Mar 24 \| 532296	4%	₹41 Cr	190,000 ↓ -60,000
Fortis Healthcare Ltd (Healthcare) Equity, Since 31 Dec 20 \| 532843	3%	₹40 Cr	465,000
Apollo Hospitals Enterprise Ltd (Healthcare) Equity, Since 30 Apr 21 \| APOLLOHOSP	3%	₹40 Cr	53,000
Gland Pharma Ltd (Healthcare) Equity, Since 30 Nov 20 \| GLAND	3%	₹34 Cr	166,863 ↓ -13,137

7. SBI Healthcare Opportunities Fund

(Erstwhile SBI Pharma Fund)

To provide the investors maximum growth opportunity through equity investments in stocks of growth oriented sectors of the economy.

Research Highlights for SBI Healthcare Opportunities Fund

Upper mid AUM (₹4,027 Cr).
Established history (20+ yrs).
Rating: 2★ (upper mid).
Risk profile: High.
5Y return: 20.54% (lower mid).
3Y return: 26.65% (upper mid).
1Y return: 6.02% (top quartile).
Alpha: 3.04 (upper mid).
Sharpe: 0.60 (top quartile).
Information ratio: 0.38 (lower mid).
Higher exposure to Health Care vs peer median.
Top bond sector: Cash Equivalent.
Equity-heavy allocation (~98%).
High-quality debt (AAA/AA ~100%).
Largest holding Sun Pharmaceuticals Industries Ltd (~11.4%).

Below is the key information for SBI Healthcare Opportunities Fund

SBI Healthcare Opportunities Fund Growth
Launch Date	31 Dec 04
NAV (04 Sep 25)	₹432.494 ↑ 0.13 (0.03 %)
Net Assets (Cr)	₹4,027 on 31 Jul 25
Category	Equity - Sectoral
AMC	SBI Funds Management Private Limited
Rating	☆☆
Risk	High
Expense Ratio	1.97
Sharpe Ratio	0.6
Information Ratio	0.38
Alpha Ratio	3.04
Min Investment	5,000
Min SIP Investment	500
Exit Load	0-15 Days (0.5%),15 Days and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
31 Aug 20	₹10,000
31 Aug 21	₹14,180
31 Aug 22	₹12,913
31 Aug 23	₹16,856
31 Aug 24	₹24,718
31 Aug 25	₹25,879

SBI Healthcare Opportunities Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹505,644.
Net Profit of ₹205,644 Invest Now

Returns for SBI Healthcare Opportunities Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 4 Sep 25

Duration	Returns
1 Month	-0.1%
3 Month	3.9%
6 Month	12.5%
1 Year	6%
3 Year	26.7%
5 Year	20.5%
10 Year
15 Year
Since launch	15.5%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	42.2%
2023	38.2%
2022	-6%
2021	20.1%
2020	65.8%
2019	-0.5%
2018	-9.9%
2017	2.1%
2016	-14%
2015	27.1%

Fund Manager information for SBI Healthcare Opportunities Fund

Name	Since	Tenure
Tanmaya Desai	1 Jun 11	14.26 Yr.

Data below for SBI Healthcare Opportunities Fund as on 31 Jul 25

Equity Sector Allocation

Sector	Value
Health Care	91.66%
Basic Materials	5.96%

Asset Allocation

Asset Class	Value
Cash	2.31%
Equity	97.62%
Debt	0.07%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Sun Pharmaceuticals Industries Ltd (Healthcare) Equity, Since 31 Dec 17 \| SUNPHARMA	11%	₹461 Cr	2,700,000 ↓ -100,000
Divi's Laboratories Ltd (Healthcare) Equity, Since 31 Mar 12 \| DIVISLAB	7%	₹290 Cr	440,000
Max Healthcare Institute Ltd Ordinary Shares (Healthcare) Equity, Since 31 Mar 21 \| MAXHEALTH	6%	₹262 Cr	2,100,000
Cipla Ltd (Healthcare) Equity, Since 31 Aug 16 \| 500087	5%	₹187 Cr	1,200,000
Lonza Group Ltd ADR (Healthcare) Equity, Since 31 Jan 24 \| LZAGY	4%	₹165 Cr	270,000 ↓ -30,000
Lupin Ltd (Healthcare) Equity, Since 31 Aug 23 \| 500257	4%	₹162 Cr	840,000
Gland Pharma Ltd (Healthcare) Equity, Since 30 Nov 20 \| GLAND	4%	₹145 Cr	700,000 ↑ 160,000
Mankind Pharma Ltd (Healthcare) Equity, Since 30 Apr 23 \| MANKIND	4%	₹144 Cr	560,000
Acutaas Chemicals Ltd (Basic Materials) Equity, Since 30 Jun 24 \| 543349	3%	₹133 Cr	1,000,000
Krishna Institute of Medical Sciences Ltd (Healthcare) Equity, Since 30 Nov 22 \| 543308	3%	₹131 Cr	1,750,000 ↓ -50,000

8. TATA India Pharma & Healthcare Fund

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns.

Research Highlights for TATA India Pharma & Healthcare Fund

Lower mid AUM (₹1,339 Cr).
Established history (9+ yrs).
Not Rated.
Risk profile: High.
5Y return: 19.34% (bottom quartile).
3Y return: 24.08% (bottom quartile).
1Y return: -0.84% (lower mid).
Alpha: 2.48 (upper mid).
Sharpe: 0.16 (upper mid).
Information ratio: 0.60 (upper mid).
Higher exposure to Health Care vs peer median.
Top bond sector: Cash Equivalent.
Equity-heavy allocation (~94%).
Largest holding Sun Pharmaceuticals Industries Ltd (~10.9%).

Below is the key information for TATA India Pharma & Healthcare Fund

TATA India Pharma & Healthcare Fund Growth
Launch Date	28 Dec 15
NAV (04 Sep 25)	₹30.7978 ↑ 0.01 (0.03 %)
Net Assets (Cr)	₹1,339 on 31 Jul 25
Category	Equity - Sectoral
AMC	Tata Asset Management Limited
Rating	Not Rated
Risk	High
Expense Ratio	2.17
Sharpe Ratio	0.16
Information Ratio	0.6
Alpha Ratio	2.48
Min Investment	5,000
Min SIP Investment	150
Exit Load	0-3 Months (0.25%),3 Months and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
31 Aug 20	₹10,000
31 Aug 21	₹14,514
31 Aug 22	₹12,943
31 Aug 23	₹15,786
31 Aug 24	₹24,599
31 Aug 25	₹24,182

TATA India Pharma & Healthcare Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹493,520.
Net Profit of ₹193,520 Invest Now

Returns for TATA India Pharma & Healthcare Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 4 Sep 25

Duration	Returns
1 Month	0.7%
3 Month	4.9%
6 Month	15%
1 Year	-0.8%
3 Year	24.1%
5 Year	19.3%
10 Year
15 Year
Since launch	12.3%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	40.4%
2023	36.6%
2022	-8%
2021	19.1%
2020	64.4%
2019	5.5%
2018	-2.6%
2017	4.7%
2016	-14.7%
2015

Fund Manager information for TATA India Pharma & Healthcare Fund

Name	Since	Tenure
Rajat Srivastava	16 Sep 24	0.96 Yr.

Data below for TATA India Pharma & Healthcare Fund as on 31 Jul 25

Equity Sector Allocation

Sector	Value
Health Care	91.69%
Financial Services	1.63%
Basic Materials	0.46%

Asset Allocation

Asset Class	Value
Cash	6.22%
Equity	93.78%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Sun Pharmaceuticals Industries Ltd (Healthcare) Equity, Since 31 Jan 16 \| SUNPHARMA	11%	₹146 Cr	856,462 ↑ 2,162
Cipla Ltd (Healthcare) Equity, Since 30 Apr 20 \| 500087	7%	₹89 Cr	569,903 ↑ 79,903
Apollo Hospitals Enterprise Ltd (Healthcare) Equity, Since 31 Dec 16 \| APOLLOHOSP	5%	₹70 Cr	92,826 ↓ -34,429
Lupin Ltd (Healthcare) Equity, Since 30 Nov 17 \| 500257	5%	₹64 Cr	330,887 ↑ 27,647
HealthCare Global Enterprises Ltd (Healthcare) Equity, Since 31 Dec 18 \| HCG	4%	₹59 Cr	942,453 ↑ 276,332
Torrent Pharmaceuticals Ltd (Healthcare) Equity, Since 31 Aug 22 \| TORNTPHARM	4%	₹58 Cr	154,717 ↑ 83,796
Aster DM Healthcare Ltd Ordinary Shares (Healthcare) Equity, Since 31 Dec 22 \| ASTERDM	4%	₹58 Cr	956,991
Fortis Healthcare Ltd (Healthcare) Equity, Since 31 Oct 20 \| 532843	4%	₹54 Cr	624,597 ↓ -230,503
Alkem Laboratories Ltd (Healthcare) Equity, Since 31 Aug 20 \| ALKEM	4%	₹54 Cr	106,435 ↑ 31,186
Max Healthcare Institute Ltd Ordinary Shares (Healthcare) Equity, Since 31 Jul 25 \| MAXHEALTH	4%	₹51 Cr	407,917 ↑ 407,917

9. IDBI Small Cap Fund

The Investment objective of the Scheme is to provide investors with the opportunities for long-term capital appreciation by investing predominantly in Equity and Equity related instruments of Small Cap companies. However there can be no assurance that the investment objective under the Scheme will be realized.

Research Highlights for IDBI Small Cap Fund

Bottom quartile AUM (₹618 Cr).
Established history (8+ yrs).
Not Rated.
Risk profile: Moderately High.
5Y return: 27.82% (upper mid).
3Y return: 16.88% (bottom quartile).
1Y return: -10.11% (bottom quartile).
Alpha: -3.30 (bottom quartile).
Sharpe: -0.45 (bottom quartile).
Information ratio: -0.66 (bottom quartile).
Top sector: Industrials.
Top bond sector: Cash Equivalent.
Equity-heavy allocation (~91%).
Largest holding Concord Enviro Systems Ltd (~2.7%).

Below is the key information for IDBI Small Cap Fund

IDBI Small Cap Fund Growth
Launch Date	21 Jun 17
NAV (04 Sep 25)	₹30.1966 ↓ -0.09 (-0.29 %)
Net Assets (Cr)	₹618 on 31 Jul 25
Category	Equity - Small Cap
AMC	IDBI Asset Management Limited
Rating	Not Rated
Risk	Moderately High
Expense Ratio	2.3
Sharpe Ratio	-0.45
Information Ratio	-0.66
Alpha Ratio	-3.3
Min Investment	5,000
Min SIP Investment	500
Exit Load	0-12 Months (1%),12 Months and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
31 Aug 20	₹10,000
31 Aug 21	₹17,956
31 Aug 22	₹21,516
31 Aug 23	₹24,879
31 Aug 24	₹38,550
31 Aug 25	₹33,751

IDBI Small Cap Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹598,181.
Net Profit of ₹298,181 Invest Now

Returns for IDBI Small Cap Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 4 Sep 25

Duration	Returns
1 Month	0.1%
3 Month	1.8%
6 Month	18.1%
1 Year	-10.1%
3 Year	16.9%
5 Year	27.8%
10 Year
15 Year
Since launch	14.4%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	40%
2023	33.4%
2022	2.4%
2021	64.7%
2020	19%
2019	-4.4%
2018	-15%
2017
2016
2015

Fund Manager information for IDBI Small Cap Fund

Name	Since	Tenure
Nikhil Rungta	1 Jul 24	1.17 Yr.
Mahesh Bendre	1 Jul 24	1.17 Yr.

Data below for IDBI Small Cap Fund as on 31 Jul 25

Equity Sector Allocation

Sector	Value
Industrials	31.47%
Consumer Cyclical	14.94%
Basic Materials	11.99%
Consumer Defensive	7.79%
Financial Services	6.74%
Utility	6.52%
Technology	6.07%
Health Care	4.1%
Communication Services	1.54%
Real Estate	0.07%

Asset Allocation

Asset Class	Value
Cash	8.77%
Equity	91.23%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Concord Enviro Systems Ltd (Utilities) Equity, Since 31 Dec 24 \| CEWATER	3%	₹17 Cr	270,441
Allied Blenders and Distillers Ltd (Consumer Defensive) Equity, Since 31 Jul 24 \| ABDL	3%	₹17 Cr	326,140
Manorama Industries Ltd (Consumer Defensive) Equity, Since 31 Dec 24 \| 541974	3%	₹17 Cr	109,106
JTL Industries Ltd (Basic Materials) Equity, Since 31 Jul 24 \| 534600	2%	₹15 Cr	2,124,029 ↓ -382,903
Navkar Corp Ltd (Industrials) Equity, Since 31 Jul 24 \| NAVKARCORP	2%	₹15 Cr	1,130,075
Arvind Fashions Ltd (Consumer Cyclical) Equity, Since 29 Feb 24 \| ARVINDFASN	2%	₹14 Cr	259,739 ↑ 28,679
Housing & Urban Development Corp Ltd (Financial Services) Equity, Since 31 Oct 24 \| HUDCO	2%	₹14 Cr	668,754
Apollo Micro Systems Ltd Ordinary Shares (Industrials) Equity, Since 30 Jun 25 \| APOLLO	2%	₹14 Cr	877,192
Syrma SGS Technology Ltd (Technology) Equity, Since 31 May 25 \| SYRMA	2%	₹14 Cr	180,780 ↑ 9,031
International Gemmological Institute (India) Ltd (Basic Materials) Equity, Since 31 Dec 24 \| IGIL	2%	₹13 Cr	337,832

10. Bandhan Infrastructure Fund

The investment objective of the scheme is to seek to generate long-term capital growth through an active diversified portfolio of predominantly equity and equity related instruments of companies that are participating in and benefiting from growth in Indian infrastructure and infrastructural related activities. However, there can be no assurance that the investment objective of the scheme will be realized.

Research Highlights for Bandhan Infrastructure Fund

Lower mid AUM (₹1,676 Cr).
Established history (14+ yrs).
Rating: 5★ (top quartile).
Risk profile: High.
5Y return: 32.31% (top quartile).
3Y return: 26.03% (upper mid).
1Y return: -11.15% (bottom quartile).
Alpha: 0.00 (bottom quartile).
Sharpe: -0.69 (bottom quartile).
Information ratio: 0.00 (bottom quartile).
Higher exposure to Industrials vs peer median.
Top bond sector: Cash Equivalent.
Equity-heavy allocation (~91%).
Largest holding Kirloskar Brothers Ltd (~5.2%).

Below is the key information for Bandhan Infrastructure Fund

Bandhan Infrastructure Fund Growth
Launch Date	8 Mar 11
NAV (04 Sep 25)	₹49.312 ↓ -0.39 (-0.78 %)
Net Assets (Cr)	₹1,676 on 31 Jul 25
Category	Equity - Sectoral
AMC	IDFC Asset Management Company Limited
Rating	☆☆☆☆☆
Risk	High
Expense Ratio	2.1
Sharpe Ratio	-0.69
Information Ratio	0
Alpha Ratio	0
Min Investment	5,000
Min SIP Investment	100
Exit Load	0-365 Days (1%),365 Days and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
31 Aug 20	₹10,000
31 Aug 21	₹19,221
31 Aug 22	₹20,185
31 Aug 23	₹26,032
31 Aug 24	₹45,976
31 Aug 25	₹39,818

Bandhan Infrastructure Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹673,113.
Net Profit of ₹373,113 Invest Now

Returns for Bandhan Infrastructure Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 4 Sep 25

Duration	Returns
1 Month	-1.3%
3 Month	-2%
6 Month	19.9%
1 Year	-11.1%
3 Year	26%
5 Year	32.3%
10 Year
15 Year
Since launch	11.6%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	39.3%
2023	50.3%
2022	1.7%
2021	64.8%
2020	6.3%
2019	-5.3%
2018	-25.9%
2017	58.7%
2016	10.7%
2015	-0.2%

Fund Manager information for Bandhan Infrastructure Fund

Name	Since	Tenure
Vishal Biraia	24 Jan 24	1.6 Yr.
Ritika Behera	7 Oct 23	1.9 Yr.
Gaurav Satra	7 Jun 24	1.24 Yr.

Data below for Bandhan Infrastructure Fund as on 31 Jul 25

Equity Sector Allocation

Sector	Value
Industrials	52.91%
Utility	12.23%
Basic Materials	7.2%
Communication Services	4.75%
Energy	3.76%
Financial Services	3.28%
Health Care	2.19%
Technology	1.74%
Consumer Cyclical	1.38%
Real Estate	1.08%

Asset Allocation

Asset Class	Value
Cash	9.47%
Equity	90.53%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Kirloskar Brothers Ltd (Industrials) Equity, Since 31 Dec 17 \| KIRLOSBROS	5%	₹87 Cr	443,385
Larsen & Toubro Ltd (Industrials) Equity, Since 29 Feb 12 \| LT	4%	₹75 Cr	206,262
Bharti Airtel Ltd (Communication Services) Equity, Since 30 Apr 19 \| BHARTIARTL	4%	₹63 Cr	330,018
Reliance Industries Ltd (Energy) Equity, Since 30 Jun 24 \| RELIANCE	4%	₹63 Cr	452,706
UltraTech Cement Ltd (Basic Materials) Equity, Since 31 Mar 14 \| 532538	4%	₹61 Cr	49,772 ↓ -680
GPT Infraprojects Ltd (Industrials) Equity, Since 30 Nov 17 \| GPTINFRA	4%	₹61 Cr	4,733,244 ↓ -49,289
Bharat Electronics Ltd (Industrials) Equity, Since 31 Oct 19 \| BEL	3%	₹55 Cr	1,431,700
PTC India Financial Services Ltd (Financial Services) Equity, Since 31 Dec 23 \| PFS	3%	₹52 Cr	12,400,122
Adani Ports & Special Economic Zone Ltd (Industrials) Equity, Since 31 Dec 23 \| ADANIPORTS	3%	₹50 Cr	365,137
Ahluwalia Contracts (India) Ltd (Industrials) Equity, Since 30 Apr 15 \| AHLUCONT	3%	₹47 Cr	462,606

Disclaimer:
ਇੱਥੇ ਪ੍ਰਦਾਨ ਕੀਤੀ ਜਾਣਕਾਰੀ ਨੂੰ ਸਹੀ ਬਣਾਉਣ ਲਈ ਸਾਰੇ ਯਤਨ ਕੀਤੇ ਗਏ ਹਨ. ਹਾਲਾਂਕਿ, ਅੰਕੜਿਆਂ ਦੀ ਸ਼ੁੱਧਤਾ ਦੇ ਸੰਬੰਧ ਵਿੱਚ ਕੋਈ ਗਰੰਟੀ ਨਹੀਂ ਦਿੱਤੀ ਜਾਂਦੀ. ਕਿਰਪਾ ਕਰਕੇ ਕੋਈ ਵੀ ਨਿਵੇਸ਼ ਕਰਨ ਤੋਂ ਪਹਿਲਾਂ ਯੋਜਨਾ ਜਾਣਕਾਰੀ ਦਸਤਾਵੇਜ਼ ਨਾਲ ਜਾਂਚ ਕਰੋ.